The presence of heterogeneous vancomycin-lntermediate Staphylococcus aureus (heteroVISA) in a major Malaysian hospital
- PMID: 23082415
The presence of heterogeneous vancomycin-lntermediate Staphylococcus aureus (heteroVISA) in a major Malaysian hospital
Abstract
This study was conducted to detect the presence of heterogenous vancomycin-intermediate Staphylococcus aureus (heteroVISA) among MRSA isolates in a major hospital. Forty-three MRSA isolates with vancomycin MIC 2 microg/ml collected in 2009 was screened for heteroVISA using Etest Glycopeptide Resistance Detection (GRD) and confirmed by population analysis profile-area under curve method. The genetic relatedness of heteroVISA strains with other MRSA was examined by pulsed-field gel electrophoresis (PFGE) method. Two isolates were shown to be heteroVISA and derived from the same clone. This showed that heteroVISA strains were already present among our local strains since 2009 and were genetically related to other susceptible strains.
Similar articles
-
Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.J Microbiol Biotechnol. 2010 Mar;20(3):637-42. J Microbiol Biotechnol. 2010. PMID: 20372039
-
Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.J Clin Microbiol. 2011 Jan;49(1):269-74. doi: 10.1128/JCM.00914-10. Epub 2010 Oct 20. J Clin Microbiol. 2011. PMID: 20962147 Free PMC article.
-
Molecular characterization of methicillin-resistant Staphylococcus aureus clones from a teaching hospital in Tehran.Jpn J Infect Dis. 2009 Jul;62(4):309-11. Jpn J Infect Dis. 2009. PMID: 19628913
-
Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it.Clin Microbiol Infect. 2009 Dec;15 Suppl 7:2-9. doi: 10.1111/j.1469-0691.2009.03094.x. Clin Microbiol Infect. 2009. PMID: 19951328 Review.
-
[Why Won't the Intractable MRSA Infections Go Away?].Seikagaku. 2016 Jun;88(3):386-90. Seikagaku. 2016. PMID: 27483957 Review. Japanese. No abstract available.
Cited by
-
Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening.PLoS One. 2015 Mar 20;10(3):e0118791. doi: 10.1371/journal.pone.0118791. eCollection 2015. PLoS One. 2015. PMID: 25793280 Free PMC article.
-
Antimicrobial heteroresistance: an emerging field in need of clarity.Clin Microbiol Rev. 2015 Jan;28(1):191-207. doi: 10.1128/CMR.00058-14. Clin Microbiol Rev. 2015. PMID: 25567227 Free PMC article. Review.
-
In vitro inhibitory and cytotoxic activity of MFM 501, a novel codonopsinine derivative, against Methicillin-Resistant Staphylococcus aureus clinical isolates.Biomed Res Int. 2015;2015:823829. doi: 10.1155/2015/823829. Epub 2015 Feb 1. Biomed Res Int. 2015. PMID: 25710030 Free PMC article.
-
Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.PLoS One. 2015 Aug 19;10(8):e0136082. doi: 10.1371/journal.pone.0136082. eCollection 2015. PLoS One. 2015. PMID: 26287490 Free PMC article.
-
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.Sci Rep. 2020 Jul 29;10(1):12689. doi: 10.1038/s41598-020-69058-z. Sci Rep. 2020. PMID: 32728110 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical